Safety Study of Albuterol Spiromax® in Subjects With Asthma
- Study Title
- Safety Study of Albuterol Spiromaxֲ® in Subjects With Asthma
- Teva Identifier
- ABS-AS-307
- ClinicalTrials.gov Identifier
- NCT01698320
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Placebo MDPI | Drug: Albuterol MDPI
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 10/01/2012 - 12/01/2013
- Phase
- Phase 3
